<unk>  is structurally similar to trabectedin, although the tetrahydroisoquinoline present in trabectedin is replaced with a tetrahydro β-carboline which enables<unk>  to exhibit increased antitumor activity compared with trabectedin.
Lurbinectedin
Paclitaxel
Doxorubicin
Busulfan
Lipoplatin
Cabazitaxel
Irinotecan
Capecitabine